Clinton Group’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2014
Q2
Sell
-5,637
Closed -$378K 310
2014
Q1
$378K Buy
5,637
+200
+4% +$13.4K 0.14% 223
2013
Q4
$350K Buy
+5,437
New +$350K 0.12% 208